supported by PON AIM(PON RICERCA E INNOVAZIONE 2014-2020,-AZIONE I.2.D.D.N.407 DEL 27 FEBBRAIO 2018-“ATTRACTION AND INTERNATIONAL MOBILITY”)(to GC);Zardi-Gori Foundation(research grant 2021)(to MS);intramural funds from the University of Cagliari(to NS);Fondazione CON IL SUD and The U.S.-Italy Fulbright Commission(to AEP).
Preclinical and clinical studies indicate that psychostimulants,in addition to having abuse potential,may elicit brain dysfunctions and/or neurotoxic effects.Central toxicity induced by psychostimulants may pose serio...
supported by the IWK Health Centre, Nova Scotia Heath Research Foundation (NSHRF), Canadian Institute of Health Research (CIHR), the Atlee Endowment and NRC-Marine Biosciences
The effects of clinically relevant doses of commonly prescribed stimulants methylphenidate (MPH), d-am- phetamine (d-AMPH), and dl-AMPH or mixed amphetamine salts (MAS) such as Adderall, on short- and long-term ...
Psychostimulants are frequently abused as a result of their stimulatory effects on several neurotransmitter systems within the central nervous system. Both dopaminergic and glutaminergic neurotransmissions have been c...